• Thumbnail for Insulin glulisine
    Insulin glulisine, sold under the brand name Apidra among others, is a rapid-acting modified form of medical insulin used for the treatment of diabetes...
    6 KB (406 words) - 08:06, 7 September 2024
  • Thumbnail for Insulin
    Garg SK (2007). "Combining insulins for optimal blood glucose control in type I and 2 diabetes: focus on insulin glulisine". Vascular Health and Risk...
    121 KB (13,799 words) - 18:53, 22 October 2024
  • acting insulin. It is approved for use in CSII pumps and Flexpen, Novopen delivery devices for subcutaneous injection. Glulisine is rapid acting insulin analog...
    22 KB (2,828 words) - 19:32, 20 December 2023
  • Thumbnail for Insulin aspart
    Insulin aspart, sold under the brand name NovoLog, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. It is...
    24 KB (1,877 words) - 07:44, 5 October 2024
  • Thumbnail for Insulin (medication)
    Aventis Lantus insulin "glargine" analogue approved for clinical use in the US and the EU. 2004 Sanofi Aventis Apidra insulin "glulisine" insulin analogue approved...
    108 KB (11,442 words) - 08:06, 5 October 2024
  • Insulin icodec, sold under the brand name Awiqli, is a medication used for the treatment of diabetes to improve glycemic control. It is an ultralong-acting...
    9 KB (521 words) - 02:56, 12 October 2024
  • of rapid-acting insulins (peak at ~1 hour) are:[citation needed] Insulin lispro (Humalog) Insulin aspart (Novolog) Insulin glulisine (Apidra) Examples...
    51 KB (5,305 words) - 19:29, 4 November 2024
  • Thumbnail for Insulin glargine
    Insulin glargine sold under the brand name Lantus among others is a long-acting modified form of medical insulin, used in the management of type I and...
    20 KB (1,637 words) - 07:49, 5 October 2024
  • Thumbnail for Dulaglutide
    being unable to produce insulin and one of the actions of dulaglutide is to stimulate functioning islet cells to produce more insulin. Dulaglutide can be...
    16 KB (1,542 words) - 20:53, 21 September 2024
  • Thumbnail for Semaglutide
    to enhance growth of pancreatic beta cells, which are responsible for insulin production and release. Additionally, it inhibits the production of glucagon...
    72 KB (6,068 words) - 21:55, 6 November 2024